Firms Hope To Adapt COVID Vaccine Trial Design, FDA Communication Approaches To Other Diseases

 
• By Sue Sutter
  
Pruning a bush
The design of Moderna's Phase III vaccine trial was pruned to answer the most important scientific questions. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from R&D

More from Pink Sheet